Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
0,33 HKD | -8,33% |
|
-2,94% | -66,67% |
Métier
Nombre d'employés: 100
Ventes par activité
HKD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
Medical Products
100,0
%
| 92 | 100,0 % | 114 | 100,0 % | +23,78% |
Ventes par région
HKD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
China
54,3
%
| 37 | 39,9 % | 62 | 54,3 % | +68,60% |
Other Regions
45,7
%
| 55 | 60,1 % | 52 | 45,7 % | -5,95% |
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
James Xue
CEO | Chief Executive Officer | 54 | 30/01/18 |
Glenn Hassan
DFI | Director of Finance/CFO | 46 | 02/04/19 |
Gerald Cox
CTO | Chief Tech/Sci/R&D Officer | - | - |
Minnie Ke
CTO | Chief Tech/Sci/R&D Officer | - | - |
Qian Ma
CMP | Compliance Officer | - | 21/06/21 |
Pauline Li
COO | Chief Operating Officer | - | 08/05/22 |
Isabella Zhao
IRC | Investor Relations Contact | - | - |
Zhang Wei
PRN | Corporate Officer/Principal | - | - |
Hu Tianxin
PRN | Corporate Officer/Principal | - | - |
Chris Chen
HRO | Human Resources Officer | - | - |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Edward Hu
BRD | Director/Board Member | 61 | 05/07/22 |
James Geraghty
BRD | Director/Board Member | 69 | 18/07/18 |
Peng Kuan Chan
BRD | Director/Board Member | 60 | 11/06/21 |
Lan Hu
BRD | Director/Board Member | 55 | 16/02/22 |
James Xue
CEO | Chief Executive Officer | 54 | 30/01/18 |
Richard Gregory
BRD | Director/Board Member | 66 | 21/04/20 |
53 | - | ||
Kan Chen
BRD | Director/Board Member | 42 | 16/12/20 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 424 838 320 | 382 281 129 ( 89,98 %) | 0 | 89,98 % |
Coordonnées société
CANbridge Pharmaceuticals Inc.
Suite 301, 3F, TImeloit No. 17 RongChuang Road
, Beijing
+86 10 6478 0016
http://www.canbridgepharma.com![Adresse CANbridge Pharmaceuticals Inc.(1228)](https://cdn.zonebourse.com/static/address/130070920.png)
Secteur
Ventes par région
![Consensus](/images/consensus_flch.gif)
Révisions de BNA
Bénéfices annuels - Taux de surprise
Varia. 1 janv. | Capi. | |
---|---|---|
-66,67% | 19,6 M | |
+15,72% | 77,62 Md | |
+13,65% | 8,98 Md | |
-24,30% | 4,33 Md | |
+12,79% | 4,21 Md | |
+31,45% | 4,1 Md | |
+10,97% | 2,19 Md | |
-30,57% | 2,04 Md | |
+8,99% | 1,94 Md | |
-45,76% | 1,69 Md |
- Bourse
- Actions
- Action 1228
- Société CANbridge Pharmaceuticals Inc.